Key result
Synthetic antisense oligodeoxynucleotides prevent cDNA elongation by AMV reverse transcriptase via RNase-H-mediated RNA degradation.
Why the study?
Synthetic oligodeoxynucleotides have been used to prevent cDNA elongation by AMV reverse transcriptase, but the mechanism of blockage needed clarification.
Antisense oligodeoxynucleotides can block AMV reverse transcriptase by inducing RNase-H-mediated degradation of the RNA template.
May inform antisense design for polymerase targets; leaves open clinical translation in cardiovascular models.
Synthetic oligodeoxynucleotides, either unmodified or linked to an intercalating agent, have been used to prevent cDNA elongation by the AMV reverse transcriptase. Oligonucleotide/RNA hybrids specifically arrest primer extension. The blockage involves the degradation of the RNA part bound to the antisense oligonucleotide by the RNase-H activity associated with the retroviral polymerase.
No takes yet. Share an insight, caveat, or question.
Loreau et al. (1990) studied this question. Synthetic antisense oligodeoxynucleotides prevent cDNA elongation by AMV reverse transcriptase by arresting primer extension through RNase-H-mediated degradation of the bound RNA.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: